Osteoclast differentiation by RANKL and OPG signaling pathways

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Journal of Bone and Mineral Metabolism

• Publication date

  2020-10-20

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00774-020-01162-6PMID 33079279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Coupling of bone resorption and formation by RANKL reverse signalling

  2018cited by this paper
• Bone Formation Is Coupled to Resorption Via Suppression of Sclerostin Expression by Osteoclasts

  2017cited by this paper
• The W9 peptide directly stimulates osteoblast differentiation via RANKL signaling

  2017cited by this paper
• Osteocyte regulation of orthodontic force-mediated tooth movement via RANKL expression

  2017cited by this paper
• Denosumab Reduces Cortical Porosity of the Proximal Femoral Shaft in Postmenopausal Women With Osteoporosis

  2016cited by this paper
• Osteoclast TGF‐β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation

  2016cited by this paper
• Coupling Signals between the Osteoclast and Osteoblast: How are Messages Transmitted between These Temporary Visitors to the Bone Surface?

  2015cited by this paper
• Osteoclast‐Derived Complement Component 3a Stimulates Osteoblast Differentiation

  2014cited by this paper
• Mechanism and Function of Monoclonal Antibodies Targeting Siglec-15 for Therapeutic Inhibition of Osteoclastic Bone Resorption*

  2014cited by this paper
• PDGF-BB secreted by preosteoclasts induces CD31hiEmcnhi vessel subtype in coupling osteogenesis

  2014cited by this paper
• EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone

  2013cited by this paper
• WNT signaling in bone homeostasis and disease: from human mutations to treatments

  2013cited by this paper
• TGF-β induces Wnt10b in osteoclasts from female mice to enhance coupling to osteoblasts.

  2013cited by this paper
• Impaired osteoclast differentiation and function and mild osteopetrosis development in Siglec-15-deficient mice.

  2013cited by this paper
• Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation.

  2013cited by this paper
• Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.

  2013cited by this paper
• Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors.

  2013cited by this paper
• Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice.

  2013cited by this paper
• Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity

  2013cited by this paper
• Siglec‐15 Regulates Osteoclast Differentiation by Modulating RANKL‐Induced Phosphatidylinositol 3‐Kinase/Akt and Erk Pathways in Association With Signaling Adaptor DAP12

  2013cited by this paper
• Siglec-15 Protein Regulates Formation of Functional Osteoclasts in Concert with DNAX-activating Protein of 12 kDa (DAP12)*

  2012cited by this paper
• Osteoprotection by semaphorin 3 A

  2012cited by this paper
• Osteoprotection by semaphorin 3A

  2012cited by this paper
• Contrasting roles of leukemia inhibitory factor in murine bone development and remodeling involve region‐specific changes in vascularization

  2012cited by this paper
• Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation.

  2011cited by this paper
• Sost down-regulation by mechanical strain in human osteoblastic cells involves PGE2 signaling via EP4

  2011cited by this paper
• Suppression of bone formation by osteoclastic expression of semaphorin 4D

  2011cited by this paper
• Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice.

  2010cited by this paper
• Bidirectional Signaling through EphrinA2-EphA2 Enhances Osteoclastogenesis and Suppresses Osteoblastogenesis*

  2009cited by this paper
• Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis

  2009cited by this paper
• Cardiotrophin‐1 Is an Osteoclast‐Derived Stimulus of Bone Formation Required for Normal Bone Remodeling

  2008cited by this paper
• Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin*

  2008cited by this paper
• NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism.

  2008cited by this paper
• Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate

  2008cited by this paper
• Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength

  2008cited by this paper
• Control of the SOST Bone Enhancer by PTH Using MEF2 Transcription Factors

  2007cited by this paper
• Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand.

  2006cited by this paper
• Role of osteoblasts in hormonal control of bone resorption—A hypothesis

  2006cited by this paper
• A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss.

  2006cited by this paper
• Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling*

  2005cited by this paper
• The Journal of Experimental Medicine CORRESPONDENCE Hiroshi Takayanagi:

  2005cited by this paper
• Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis

  2004cited by this paper
• Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice.

  2003cited by this paper
• Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption.

  2003cited by this paper
• Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

  2002cited by this paper
• Large Scale Gene Expression Analysis of Osteoclastogenesisin Vitro and Elucidation of NFAT2 as a Key Regulator*

  2002cited by this paper
• Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.

  2000cited by this paper
• RANK is essential for osteoclast and lymph node development.

  1999cited by this paper
• OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

  1999cited by this paper
• Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.

  1999cited by this paper
• Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

  1998cited by this paper
• osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.

  1998cited by this paper
• Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.

  1998cited by this paper
• Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.

  1998cited by this paper
• Structure–based design and characterization of exocyclic peptidomimetics that inhibit TNFα binding to its receptor

  1997cited by this paper
• Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

  1997cited by this paper
• Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNF alpha binding to its receptor.

  1997cited by this paper
• The effect of leukemia inhibitory factor on bone in vivo.

  1993cited by this paper
• The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

  1990cited by this paper
• Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells.

  1990cited by this paper
• Osteoblastic cells are involved in osteoclast formation.

  1988cited by this paper

• Chemoattractive potential of stem cells from apical papilla in peripheral blood monocytes: an in vitro study

  2026influential citation
• KLF2 interacts with AP-1 to negatively affect osteoclast differentiation and activity.

  2026cites this paper
• Effects of dietary vitamin D supplementation on bone microarchitecture, mineralization, and mechanical properties in Wistar rat animal model.

  2026cites this paper
• Plant-derived food bioactives in bone health: from multi-targeted roles to molecular mechanisms in osteoporosis

  2026cites this paper
• Medicinal-chemistry-driven strategies for the synthesis of antiosteoclastogenic small molecules targeting RANKL and its downstream signaling pathways.

  2026cites this paper
• Primary Biliary Cholangitis–associated Osteoporosis: Contemporary Review of Pathogenesis and Management

  2026cites this paper
• Desmethoxyyangonin, a Potent Cannabinoid Receptor 2 Agonist, Alleviates Bone Loss in Ovariectomized Mice via Dual Regulation of Osteoblast and Osteoclast Function.

  2026cites this paper
• Nuclear factor I/A: A novel multifunctional player in bone homeostasis via coordinating osteoclast and osteoblast differentiation

  2026cites this paper
• Cell signaling and transcriptional regulation of osteoclast lineage commitment, differentiation, bone resorption and diseases

  2026cites this paper
• Pan-cancer bone metastasis atlas at single-cell resolution identifies a distinct tumor-associated macrophage subset for mediating Denosumab-induced immunosensitization in lung cancer bone metastasis

  2026cites this paper
• The relationship between the polymorphisms and mutations of OPG gene and bone metabolism in postmenopausal women in northwest China.

  2026cites this paper
• Research Progress on Dance Training as a Mechanical Stimulus for the Prevention and Treatment of Osteoporosis: A Narrative Review

  2026cites this paper
• L-Quebrachitol Attenuates RANKL-Induced Osteoclastogenesis and Bone Resorption in Ovariectomized Rat Model

  2026cites this paper
• The receptor activator of nuclear factor κB ligand (RANKL) regulates the biological behavior of trophoblasts through the PI3K/Akt signaling pathway.

  2026cites this paper
• Mechanisms and Therapeutic Potential of Stem Cell‐Derived Extracellular Vesicles as Nanocarriers in Musculoskeletal Disorders

  2026cites this paper
• Black Phosphorus Nanomaterials and the Senescent Osteoimmune Microenvironment: Mechanisms, Opportunities, Challenges, and Future Outlook

  2026cites this paper
• ATF5-mediated mitochondrial UPR inhibited RANKL in Porphyromonas gingivalis LPS-treated osteoblasts.

  2026cites this paper
• Immune reprogramming in the bone marrow microenvironment: a new perspective on the bone immune microenvironment of postmenopausal osteoporosis

  2026cites this paper
• Bone turnover markers in patients with inflammatory bowel disease in remission: a cross-sectional comparison of anti-TNFα therapy with conventional maintenance therapy.

  2026cites this paper
• Research progress on the effects of macrophage-derived exosomes on muscle factors IGF-1 and FGF-2 mediating musculoskeletal crosstalk molecular signaling pathway on bone metabolism (Review)

  2026cites this paper
• Determination of the binding affinity between osteoprotegerin (OPG) and receptor activator of nuclear factor-κB ligand (RANKL) utilizing Gaussia luciferase in living cells.

  2026cites this paper
• Inflammatory Mediators in Peri-Implantitis: From Pathophysiology to Therapeutic Targets.

  2026cites this paper
• Deciphering Multitarget Mechanisms of Phytochemical Flavonoids From Traditional Chinese Medicine: Emerging Insights Into Osteoporosis Therapeutics

  2026cites this paper
• Downregulation of osteoclast differentiation and activation by the soluble epoxide hydrolase inhibition.

  2026cites this paper
• Lactate targeting: Regulatory networks and therapeutic potential in bone diseases.

  2026cites this paper
• Traditional Medicine-Derived Natural Products as Anti-Osteoporotic Agents: A Review on Structural Modifications, Mechanisms, and Structure-Activity Relationships

  2026cites this paper
• Gαi1/3 Is a Novel Regulatory Target for RANKL Signal Transduction and Osteoporosis.

  2026cites this paper
• Microvascular Endothelial Cell-Derived Exosomes Decrease Osteoclastogenesis by Restraining Osteoclast Ferroptosis through the USP13/NRF2/GPX4 Pathway.

  2025cites this paper
• Improvement Effect and Regulation Mechanism of Oyster Peptide on Dexamethasone-Induced Osteoporotic Rats

  2025cites this paper
• Sphenoid sinus hyperpneumatization: anatomical variants, molecular blueprints, and AI-augmented roadmaps for skull base surgery

  2025cites this paper
• Progress in immunoregulatory mechanisms during distraction osteogenesis

  2025cites this paper
• Ferroptosis in patients with rheumatoid arthritis.

  2025cites this paper
• Critical signaling pathways in osteoclast differentiation and bone resorption: mechanisms and therapeutic implications for periprosthetic osteolysis

  2025cites this paper
• Kaempferol—A Natural Drug for Rheumatoid Arthritis

  2025cites this paper
• Research progress on mesenchymal stem cell-derived exosomes in the treatment of osteoporosis induced by knee osteoarthritis (Review)

  2025cites this paper
• Effects of Epigallocatechin-3-O-Gallate on Bone Health

  2025cites this paper
• Crebanine protects against ovariectomy-induced bone loss by targeting Sirt1 to interfere with NF-κB acetylation and ROS activity

  2025cites this paper
• The role of TRIM proteins in chronic inflammation-associated musculoskeletal diseases.

  2025cites this paper
• Therapeutic Potential of Ginsenosides in the Treatment of Endocrine Diseases: Roles and Mechanisms

  2025influential citation
• The Role of Cytokines in Orthodontic Tooth Movement

  2025cites this paper
• Mechanisms underlying ESWT-induced osteogenesis: a review of molecular and cellular pathways

  2025cites this paper
• Exploring Macrophage Contribution to Vascular Calcification in Atherosclerosis

  2025cites this paper
• Metabolically Engineered Extracellular Vesicles Released From a Composite Hydrogel Delivery System Regulate the Microenvironment for Periprosthetic Osteolysis Treatment

  2025cites this paper
• Targeted delivery of sinomenine hydrochloride using recombinant ferritin nanocages for rheumatoid arthritis treatment.

  2025cites this paper
• Galanin receptor agonists limit osteoclast number in in vitro mouse models

  2025cites this paper
• Self‐Replenishable Metabolically Augmented Synbiotic Microspheres Remodel Gut‐Bone Homeostasis

  2025cites this paper
• PTH stimulation of Rankl transcription is regulated by SIK2 and 3 and mediated by CRTC2 and 3 through action of protein phosphatases 1, 2, 4, and 5

  2025cites this paper
• Tectorigenin Ameliorates Glucocorticoid‐Induced Osteoporosis by Inhibiting the NF‐κB Signal Pathway and Modulating Treg‐Th17 Cell Balance

  2025cites this paper
• Antioxidative fullerol prevents bone loss due to its anti-osteoclastogenic and pro-osteogenic activities.

  2025cites this paper
• Metformin facilitates osteogenic differentiation of bone marrow stromal cells through AMPK-dependent autophagy: an investigation into the healing of osteoporotic fractures in murine models

  2025cites this paper
• The unexplored relationship between spontaneous osteoclastogenesis and platelets in osteoporosis

  2025cites this paper
• The mechanism of NK cell expression of RANKL/RANK/OPG pathway in mouse models of femoral head necrosis

  2025cites this paper
• Osteoporosis-alleviating Effects of Unsaponifiable Matter Derived from Chlorella sp. Lipids on Bone Regeneration promotion and Bone Matrix Enhancement in Ovariectomized C57BL/6 Mouse Model

  2025cites this paper
• Inhibitory effects of Lycii fructus water extracts and its active ingredient, zeaxanthin, on receptor activator of nuclear factor κB ligand-induced osteoclast differentiation

  2025cites this paper
• Osteocyte dysregulation in periodontitis: Pathological mechanisms and therapeutic potential.

  2025cites this paper
• Age- and sex-associated effects of C18 ceramide sphingolipids on osteoclastogenesis in experimental models of Gulf War Illness

  2025cites this paper
• Complexed Micelles System Based on Ceria Oxide Nanozyme for Bone Remodeling and ROS Scavenging in Periodontitis

  2025cites this paper
• Research progress on the effects and mechanisms of different cell types on osteoclast differentiation in bone metabolism in rheumatoid arthritis

  2025influential citation
• Functionalized metal-organic framework and MOF-derived materials for bone regeneration applications

  2025cites this paper
• Exploring the Interaction Between Sjögren’s Syndrome and Osteoporosis: Pathophysiological Mechanisms and Management Strategies

  2025cites this paper
• Coptidis Rhizoma Water Extract Attenuates RANKL-Induced Osteoclast Differentiation via MAPK, Akt, and NF-κB Pathways and Prevents Ovariectomy (OVX)-Mediated Bone Loss

  2025cites this paper
• Fabkin Promoted Osteoclasts Mature and Bone Loss in OVX‐Induced Osteoporosis Mice

  2025cites this paper
• The Mechanosensitive PIEZO1 Channel Contributes to the Reaction of RAW264.7 Macrophages to Mechanical Strain

  2025cites this paper
• Advances in the study and treatment of glucocorticoid osteoporosis: A review

  2025cites this paper
• TGF-β1 regulates pannexin1 channels and evokes apoptotic response in osteoblasts.

  2025cites this paper
• Nanometer preparation of natural bioactive compounds for treatment of rheumatoid arthritis

  2025cites this paper
• The effect of eight different gene polymorphisms on osteopenia and osteoporosis in the Turkish population

  2025cites this paper
• In Silico Screening and Identification of Functional Peptides from Yak Bone Collagen Hydrolysates: Antioxidant and Osteoblastic Activities

  2025influential citation
• Efficacy of spinal fusion in Brucella spondylitis: a systematic review

  2025cites this paper
• Ras-proximate-1 (RAP1): a prognosis and therapeutic target in the metastatic spread of breast cancer

  2025cites this paper
• Research progress on osteoclast regulation by biodegradable magnesium and its mechanism

  2025cites this paper
• Branched-chain amino acid metabolic disorder promotes osteoporosis by inhibiting HIF1-α-mediated glycolytic reprogramming in osteoblasts

  2025cites this paper
• Exploring causal correlations between inflammatory response-related genes and osteoporosis: a Multi-Omics Mendelian Randomization Study

  2025cites this paper
• Age-related alterations of angiogenesis, inflammation and bone microarchitecture during fracture healing in mice

  2025cites this paper
• Beyond Bone Remodeling: Denosumab’s Multisystemic Benefits in Musculoskeletal Health, Metabolism, and Age-Related Diseases—A Narrative Review

  2025cites this paper
• Global knowledge mapping of receptor activator of nuclear factor kappa-B ligand in osteoporotic fractures: a bibliometric analysis (2001–2024)

  2025cites this paper
• The role of calcium ions and the transient receptor potential vanilloid (TRPV) channel in bone remodelling and orthodontic tooth movement

  2025cites this paper
• Effects of traditional Chinese medicine pyritum on orthodontic tooth movement in rats.

  2025cites this paper
• Zuogui Wan attenuates ovariectomy-induced osteoporosis via the GH/IGF1 axis and related pathways

  2025cites this paper
• Fused exosomal targeted therapy in periprosthetic osteolysis through regulation of bone metabolic homeostasis

  2025cites this paper
• Bone Modelling and Remodelling in Cold Environment

  2025cites this paper
• Research Progress on the Role and Intervention of the MAPK Signaling Pathway in the Imbalance of Bone Remodeling in Postmenopausal Osteoporosis

  2025cites this paper
• MiRNA-mRNA network in osteoporotic fractures proposes the functional mechanism of hsa-miR-32-3p/TNFSF11 axis

  2025cites this paper
• Brevilin A, a novel BNIP3 inhibitor suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss via impairing mitophagy and mitochondrial metabolism.

  2025cites this paper
• Role of Masticatory Force in Modulating Jawbone Immunity and Bone Homeostasis: A Review

  2025cites this paper
• Parthenolide ameliorates glucocorticoid-induced inhibition of osteogenic differentiation and osteoporosis by activating ERK signaling pathway

  2025cites this paper
• Salidroside inhibits osteoclast differentiation based on osteoblast-osteoclast interaction via HIF-1a pathway.

  2025cites this paper
• TNFRSF11B-modified umbilical cord mesenchymal stem cells as a novel strategy for bone-related diseases by suppressing osteoclast activity

  2025cites this paper
• Effect of microgravity on bone Tissue: Mechanisms of osteodegeneration and advanced treatment modalities.

  2025cites this paper
• Murine Osteoblast and Osteoclast Co-culture on Demineralized Bone Paper for Bone Remodeling

  2025cites this paper
• RNA interference-mediated osteoprotegerin silencing increases the receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio and promotes osteoclastogenesis

  2025cites this paper
• Toll-like receptor engaged in activation and osteoimmuno-cytokines production by unswitched memory B cells during periodontitis

  2025cites this paper
• Direct and indirect effects of transforming growth factor-beta on osteoclast-mediated bone remodeling using a new in vitro bone matrix model

  2025cites this paper
• Ferritin promotes monocyte osteoclastogenic differentiation to aggravate alveolar bone resorption in periodontitis

  2025cites this paper
• Inhibition of CD38 by 78c Enhanced NAD+, Alleviated Inflammation, and Decreased Oxidative Stress in Old Murine Macrophages Induced by Oral Pathogens

  2025cites this paper
• Deciphering the role of ERK and PI3K/Akt as crosstalk pathways between fibroblast-like synoviocytes and osteoclasts; novel therapeutic approach for rheumatoid arthritis

  2025cites this paper
• Dietary fiber derived short-chain fatty acids as a critical driver of the gut–bone axis in animal bone health: A review

  2025cites this paper
• Effect of hyperbaric oxygen therapy (HBO) on osteoblasts of elderly patients on calcification and osteoprotegerin

  2025cites this paper
• CX3CL1 promotes M1 macrophage polarization and osteoclast differentiation via NSUN5-mediated m5C modification

  2025cites this paper
• Atractylenolide I Attenuates Glucocorticoid-Induced Osteoporosis via Inhibiting NF-κB Signaling Pathway

  2025cites this paper